Real Leaders. Real Challenges.
Learn from anonymized case studies of biopharmaceutical executives navigating complex leadership situations using the 7+3 framework.
Case Study: Chris
The Challenge
Chris inherited a Medical Affairs team with low morale and high attrition. The team felt micromanaged by the previous VP and lacked psychological safety to voice concerns or propose innovative approaches.
The Approach
Chris focused on rebuilding Presence and Trust. He implemented weekly 1:1s, opened decision-making processes, and publicly acknowledged when team members brought forward dissenting views. He delegated authority for regional strategy while maintaining accountability through outcome metrics.
Outcome: Within 6 months, team engagement scores increased by 40%, attrition dropped to zero, and the team proposed 3 innovative medical education programs that were successfully implemented.
Case Study: Kai
The Challenge
Kai managed 5 direct reports who each managed large teams. Kai felt overwhelmed by tactical decisions that should have been delegated. His calendar was consumed by "urgent" operational issues, leaving no time for strategic planning.
The Approach
Kai implemented the ACID framework (Authority, Consult, Inform, Delegate) with his leadership team. He mapped decision rights clearly and established guardrails for when escalation was truly needed. He trained his direct reports on autonomous decision-making within defined boundaries.
Outcome: Kai reclaimed 15 hours per week for strategic work. His team reported increased confidence in decision-making. Clinical trial timelines improved by 12% due to faster operational decisions.
Case Study: Lane
The Challenge
Lane had deep technical expertise but struggled to influence cross-functional stakeholders. Commercial and R&D teams viewed Regulatory as a "blocker" rather than a strategic partner. Lane's recommendations were frequently ignored until crises emerged.
The Approach
Lane focused on building Authority through proactive stakeholder engagement. Instead of reactive compliance reviews, he initiated quarterly "regulatory roadmap" sessions where he educated other functions on upcoming requirements. He positioned Regulatory as a strategic advisor, not a gatekeeper.
Outcome: Within 15 months, Lane's authority shifted from "positional" to "personally earned." He was invited into strategy discussions early, and cross-functional teams began seeking his input proactively. No regulatory compliance issues occurred in the following 18 months.
How Would You Handle These Situations?
Take the LeaderFit Assessment to understand your current leadership profile and identify which Conditions and Capacities you should prioritize for development.
Take LeaderFit Assessment